Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.

Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):429-35.

PMID:
16255753
2.

Implantable cardioverter-defibrillators: a new preventive medical option.

Glatter KA, Young JN, McElvany MD.

Prev Cardiol. 2006 Winter;9(1):49-53; quiz 54-5. Review.

3.

Amiodarone: clinical trials.

Naccarelli GV, Wolbrette DL, Patel HM, Luck JC.

Curr Opin Cardiol. 2000 Jan;15(1):64-72. Review.

PMID:
10666663
4.
5.

Implantable cardioverter defibrillator therapy in postinfarction patients.

Zareba W.

Curr Opin Cardiol. 2004 Nov;19(6):619-24. Review.

PMID:
15502509
6.

Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.

Hilleman DE, Bauman AL.

Pharmacotherapy. 2001 May;21(5):556-75. Review.

PMID:
11349745
7.

Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence.

Lynd LD, O'Brien BJ.

J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S99-103. Review.

PMID:
12950529
9.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
11.

Device therapy for heart failure.

Boehmer JP.

Am J Cardiol. 2003 Mar 20;91(6A):53D-59D. Review.

PMID:
12670643
12.
13.

Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.

Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV.

Circ Arrhythm Electrophysiol. 2014 Feb;7(1):164-70. doi: 10.1161/CIRCEP.113.001217. Epub 2014 Jan 20. Review.

14.

Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?

Fazal IA, Bates MG, Matthews IG, Turley AJ.

Interact Cardiovasc Thorac Surg. 2011 Jun;12(6):1010-6. doi: 10.1510/icvts.2010.259465. Epub 2011 Mar 11. Review.

PMID:
21398652
16.

Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.

Freeman JV, Masoudi FA.

Heart Fail Clin. 2013 Jan;9(1):59-77. doi: 10.1016/j.hfc.2012.09.006. Epub 2012 Oct 13. Review.

PMID:
23168318
17.

Antiarrhythmic therapy in heart failure.

Eckardt L, Haverkamp W, Breithardt G.

Heart Fail Monit. 2002;2(4):110-9. Review.

PMID:
12634885
18.

[The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives].

Brachmann J, Hilbel T, Schöls W, Beyer T, Schweizer M, Sterns L, Karolyi L, Melichercik J, Freigang KD, Kübler W.

Herz. 1994 Oct;19(5):246-50. Review. German.

PMID:
8001897
19.

A review of the implantable cardioverter defibrillator trials.

Cannom DS.

Curr Opin Cardiol. 1998 Jan;13(1):3-8. Review.

PMID:
9559251
20.

Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death [Internet].

Uhlig K, Balk EM, Earley A, Persson R, Garlitski AC, Chen M, Lamont JL, Miligkos M, Avendano EE.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26.

Supplemental Content

Support Center